2026 Summer Intern – Uro-Oncology, PR & Communications at Acadia Pharmaceuticals

Parsippany, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biopharmaceutical, Uro-Oncology, PharmaceuticalIndustries

Requirements

Pursuing a degree in Communications, PR, Marketing, or related field
Strong storytelling and communication skills, written and verbal
Comfortable juggling multiple projects and collaborating with diverse teams
Previous PR, communications, or customer-facing experience a plus
Curious about the healthcare or pharmaceutical world
Ability to complete the entire 10-week program (from May 26, 2026 to July 31, 2026) and commit to 37.5 hours per week
Cumulative 3.0 GPA or above; college transcript required (must mail official transcript by application deadline)
Currently enrolled in an accredited U.S. based college or university
Enrolled in either an undergraduate (Bachelor’s), graduate, MBA, JD, PharmD, or PhD program
Legally authorized to work in the U.S. without a need for sponsorship/CPT
For Parsippany-based roles: Expected to work no less than 4 days at the site in Parsippany, New Jersey, on days in conjunction with assigned team; may work 1 day per week remotely

Responsibilities

Collaborate with the PR & Communications team and agency partners to support the development of internal and external communication materials, including press releases, key messages, and digital content
Assist in planning and coordinating communication initiatives that highlight brand milestones, patient stories, and corporate achievements
Support media monitoring and reporting, helping track coverage, sentiment, and emerging topics relevant to the Uro-Oncology space
Contribute to the development of content for internal channels, including newsletters, intranet posts, and leadership communications
Enroll in and complete the Ferring Academy of Marketing Excellence training curriculum

Skills

Key technologies and capabilities for this role

PRCommunicationsMedia RelationsContent CreationMessagingPublic RelationsBrand AwarenessInternal CommunicationsExternal CommunicationsCommunication Strategies

Questions & Answers

Common questions about this position

What degree is required for the 2026 Summer Intern – Uro-Oncology PR & Communications role?

Candidates must be pursuing a degree in Communications, PR, Marketing, or a related field.

What key skills are needed for this internship?

The role requires strong storytelling and communication skills, both written and verbal, and comfort juggling multiple projects.

What does the company culture at Ferring emphasize?

Ferring cultivates an entrepreneurial spirit, long-term perspective, agility, and a 'people first' philosophy, and is Great Places to Work® Certified.

Is this a remote position or does it require office work?

This information is not specified in the job description.

What is the compensation for this summer internship?

This information is not specified in the job description.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free